ADA Scientific Sessions 2026 Abstract

Therapeutic Transition to Weekly Basal Insulin Icodec plus Tirzepatide in Type 2 Diabetes: An Early Real-World Experience

By Giada Rossi, Laura Montefusco, Ida Pastore, Paolo Fiorina

Study in peopleInterventions

The paper

Giada Rossi, Laura Montefusco, Ida Pastore, Paolo Fiorina

Milan

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1811-P

doi.org/10.2337/db26-1811-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety